Pivotal bioVenture Partners Fund I G.P., L.P.
Insider CIK 1752862 · INZY Director, 10% owner · AKUS 10% owner · ETTX 10% owner · EVMN Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EVMN Evommune, Inc. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 313,571 | — | $0 | 0 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 313,571 | — | $0 | 0 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 2,508,575 | — | $0 | 0 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 7,145,647 | — | $0 | 0 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 3,572,816 | — | $0 | 0 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 2,582,243 | — | $0 | 0 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 7,230,283 | — | $0 | 0 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 1,895,260 | — | $0 | 0 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 2,104,740 | — | $0 | 0 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion | 2025-11-07 | 2025-11-12 | 294,502 | — | $0 | 294,502 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion | 2025-11-07 | 2025-11-12 | 1,441,032 | — | $0 | 1,441,032 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion | 2025-11-07 | 2025-11-12 | 1,632,441 | — | $0 | 1,632,441 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2023-08-01 | 2023-08-03 | 119,048 | $4.80 | $571.4K | 2,923,110 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2023-08-01 | 2023-08-03 | 714,285 | $4.80 | $3.43M | 1,571,741 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2022-04-19 | 2022-04-20 | 1,070,000 | $3.69 | $3.95M | 2,661,154 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 10,489,510 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2020-07-28 | 2020-07-28 | 187,500 | $16.00 | $3.00M | 1,591,154 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 1,403,654 | — | $0 | 1,403,654 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 1,499,971 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 1,499,971 | — | $0 | 1,499,971 | SEC↗ |
| AKUS Akouos, Inc. | P Buy | 2020-06-30 | 2020-07-01 | 294,117 | $17.00 | $5.00M | 1,794,088 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 9,502,249 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 7,446,904 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | P Buy | 2018-09-28 | 2018-10-02 | 337,724 | $15.00 | $5.07M | 1,180,178 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 458,425 | — | $0 | 842,454 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 359,267 | — | $0 | 359,267 | SEC↗ |